Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

被引：0
|
作者：
Markus Luster
Martin Schlumberger
Furio Pacini
机构：
[1] University of Ulm,Department of Nuclear Medicine
[2] Institut Gustave Rousy,Department of Nuclear Medicine and Endocrine Oncology
[3] University of Siena,Department of Internal Medicine, Section of Endocrinology & Metabolism
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2009年 / 36卷
关键词：
Thyroid Cancer; Hypothyroidism; Thyroglobulin; Differentiate Thyroid Cancer; Serum Thyroglobulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：329 / 330
页数：1
相关论文
共 50 条
  • [21] Recombinant human thyrotropin in follow-up of patients with differentiated thyroid cancer
    Podoba, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2010, 111 (01): : 38 - 40
  • [22] THE ROLE OF RECOMBINANT HUMAN THYROTROPIN FOR DIAGNOSTIC MONITORING OF PATIENTS WITH DIFFERENTIATED THYROID CANCER
    Sherman, Steven I.
    ENDOCRINE PRACTICE, 2013, 19 (01) : 157 - 161
  • [23] Indirect Basal Metabolism Estimation in Tailoring Recombinant Human TSH Administration in Patients Affected by Differentiated Thyroid Cancer: A Hypothesis-Generating Study
    Barnabei, Agnese
    Strigari, Lidia
    Persichetti, Agnese
    Baldelli, Roberto
    Rizza, Laura
    Annoscia, Claudia
    Lauretta, Rosa
    Cigliana, Giovanni
    Barba, Maddalena
    De Leo, Aurora
    Appetecchia, Marialuisa
    Torino, Francesco
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [24] Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer
    Kraenzlin, ME
    Meier, C
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (02) : 167 - 176
  • [25] Reduced insulin sensitivity in differentiated thyroid cancer patients with suppressed TSH
    De Melo, Thais Gomes
    Souza, Aglecio Luiz
    Ficher, Elizabeth
    Fernandes, Arlete Maria
    Montali Da Assumpcao, Ligia Vera
    Alegre, Sarah Monte
    Zantut-Wittmann, Denise Engelbrecht
    ENDOCRINE RESEARCH, 2018, 43 (02) : 73 - 79
  • [26] Role of Recombinant Human Thyrotropin (rhTSH) in the Treatment of Well-Differentiated Thyroid Cancer
    Robenshtok, E.
    Tuttle, R. Michael
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2012, 3 (03) : 182 - 189
  • [27] Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer
    Mariani, G
    Ferdeghini, M
    Augeri, C
    Villa, G
    Taddei, GZ
    Scopinaro, G
    Boni, G
    Bodei, L
    Rabitti, C
    Molinari, E
    Bianchi, R
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2000, 15 (02) : 211 - 217
  • [28] Role of Recombinant Human Thyrotropin (rhTSH) in the Treatment of Well-Differentiated Thyroid Cancer
    E. Robenshtok
    R. Michael Tuttle
    Indian Journal of Surgical Oncology, 2012, 3 (3) : 182 - 189
  • [29] Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone
    G. Berg
    G. Lindstedt
    M. Suurküla
    S. Jansson
    Journal of Endocrinological Investigation, 2002, 25 : 44 - 52
  • [30] Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone
    Berg, G
    Lindstedt, G
    Suurküla, M
    Jansson, S
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (01) : 44 - 52
12345